As expected, a subset of p53+/− and p53−/− mice developed nonmammary tumors (either thymic lymphomas or sarcomas), consistent with published reports (Jacks et al. 1994; Sandgren et al. 1995; Dannenberg et al. 2000). Here, TP53 is linked to sarcoma.